UVE vs. CTMX
UVE (Universal Insurance Holdings, Inc.) and CTMX (CytomX Therapeutics, Inc.) are both stocks. UVE operates in Insurance - Property & Casualty (Financial Services), while CTMX operates in Biotechnology (Healthcare). Over the past 10 years, UVE returned 11.88%/yr vs -11.07%/yr for CTMX. At a 0.10 correlation, their price movements are largely independent.
Performance
UVE vs. CTMX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UVE achieves a 14.34% return, which is significantly higher than CTMX's -28.64% return. Over the past 10 years, UVE has outperformed CTMX with an annualized return of 11.88%, while CTMX has yielded a comparatively lower -11.07% annualized return.
UVE
- 1D
- 0.58%
- 1M
- -1.69%
- YTD
- 14.34%
- 6M
- 11.60%
- 1Y
- 48.79%
- 3Y*
- 39.71%
- 5Y*
- 28.20%
- 10Y*
- 11.88%
CTMX
- 1D
- 3.05%
- 1M
- -19.15%
- YTD
- -28.64%
- 6M
- -26.21%
- 1Y
- 31.03%
- 3Y*
- 25.44%
- 5Y*
- -14.57%
- 10Y*
- -11.07%
UVE vs. CTMX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UVE Universal Insurance Holdings, Inc. | 14.34% | 65.32% | 36.80% | 58.14% | -33.52% | 18.39% | -43.50% | -24.24% | 41.44% | -0.88% |
CTMX CytomX Therapeutics, Inc. | -28.64% | 313.59% | -33.55% | -3.13% | -63.05% | -33.89% | -21.18% | -44.97% | -28.47% | 92.08% |
Correlation
The correlation between UVE and CTMX is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.00 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.03 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Oct 8, 2015 | 0.10 |
The correlation between UVE and CTMX shifts across timeframes, from -0.11 (1 year) to 0.10 (all time), reflecting how their relationship changes across market environments.
Fundamentals
UVE:
$9.07
CTMX:
-$0.37
UVE:
0.52
CTMX:
13.72
UVE:
$1.60B
CTMX:
$35.54M
UVE:
$346.30M
CTMX:
$24.77M
UVE:
$272.42M
CTMX:
-$62.07M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UVE vs. CTMX — Risk / Return Rank
UVE
CTMX
UVE vs. CTMX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Universal Insurance Holdings, Inc. (UVE) and CytomX Therapeutics, Inc. (CTMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UVE | CTMX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.01 | ||
| Sortino ratioReturn per unit of downside risk | +0.80 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.16 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 2.76 | 0.55 | +2.22 |
| Martin ratioReturn relative to average drawdown | 5.75 | 1.29 | +4.45 |
Loading charts...
Drawdowns
UVE vs. CTMX - Drawdown Comparison
The maximum UVE drawdown since its inception was -80.46%, smaller than the maximum CTMX drawdown of -98.74%. Use the drawdown chart below to compare losses from any high point for UVE and CTMX.
Loading charts...
Drawdown Indicators
| UVE | CTMX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.46% | -98.74% | +18.28% |
Max Drawdown (1Y)Largest decline over 1 year | -17.74% | -56.89% | +39.15% |
Max Drawdown (3Y)Largest decline over 3 years | -25.75% | -91.59% | +65.84% |
Max Drawdown (5Y)Largest decline over 5 years | -54.23% | -94.16% | +39.93% |
Max Drawdown (10Y)Largest decline over 10 years | -79.58% | -98.74% | +19.16% |
Current DrawdownCurrent decline from peak | -6.76% | -91.12% | +84.36% |
Average DrawdownAverage peak-to-trough decline | -36.27% | -70.93% | +34.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.51% | 24.04% | -15.53% |
Volatility
UVE vs. CTMX - Volatility Comparison
The current volatility for Universal Insurance Holdings, Inc. (UVE) is 8.18%, while CytomX Therapeutics, Inc. (CTMX) has a volatility of 14.08%. This indicates that UVE experiences smaller price fluctuations and is considered to be less risky than CTMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UVE | CTMX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.18% | 14.08% | -5.90% |
Volatility (6M)Calculated over the trailing 6-month period | 26.69% | 67.28% | -40.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.67% | 93.83% | -57.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.20% | 141.88% | -99.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.34% | 111.37% | -70.03% |
Dividends
UVE vs. CTMX - Dividend Comparison
UVE's dividend yield for the trailing twelve months is around 2.01%, while CTMX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTMX CytomX Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
UVE Universal Insurance Holdings, Inc. | 2.01% | 2.28% | 3.66% | 4.82% | 7.27% | 4.53% | 5.10% | 2.75% | 1.93% | 2.52% | 2.43% | 2.72% |
Financials
UVE vs. CTMX - Financials Comparison
This section allows you to compare key financial metrics between Universal Insurance Holdings, Inc. and CytomX Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
UVE and CTMX have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CTMX has higher volatility (14.08%) compared to UVE (8.18%). In terms of maximum drawdown, UVE dropped -80.46% vs CTMX's -98.74%.
UVE currently has the higher Sharpe Ratio (1.34 vs 0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UVE and CTMX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer